Author

O. Popova

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Assay:flow cytometry· 1 Organism:human· 1 Assay:imaging· 1

Frequent Co-Authors

A. Alfranca· 1 shared A. Balazs· 1 shared A. L. Gintsburg· 1 shared A. S. Bandelyuk· 1 shared A. S. Dzharullaeva· 1 shared B. S. Naroditskiy· 1 shared C. D. Arevalo· 1 shared C. M. Calleja· 1 shared

Activity by Year

2022-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Alfranca

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Combined Dendritic Cell And Anti-TIGIT Immunotherapy Potentiate Trail+ Memory NK Cells Against HIV-1 Infected Cells

I. S. Cerrillo, O. Popova, M. A. Lera, I. Tsukalov, M. C. Mirabent, I. Santos, L. G. Fraile, P. Fuentes, C. D. Arevalo, J. Alcain, N. S. Gaona, M. L. Diez, C. M. Calleja, A. Alfranca, M. Genesca, , E. Martin-Gayo

Combining dendritic cell stimulation with anti-TIGIT antibodies enhances memory NK cell cytotoxicity against HIV-1 infected CD4+ T cells in vitro and in vivo.

bioRxiv · Apr 9, 2024 · PreprintImmunology

Cross-reactive single-domain antibodies to hemagglutinin stem region protect mice from group 1 influenza A virus infection

D. V. Voronina, A. S. Bandelyuk, A. S. Dzharullaeva, O. Popova, V. Y. Kan, I. B. Esmagambetov, I. A. Favorskaya, D. V. Shcheblyakov, B. S. Naroditskiy, A. L. Gintsburg

This study modifies two single-domain antibodies to enhance their neutralizing activity against multiple influenza A virus subtypes and demonstrates their protective efficacy in mice.

bioRxiv · Sep 29, 2022 · PreprintImmunology